Shares of Aytu Biopharma Inc (NASDAQ:AYTU) rose sharply in pre-market trading after the pharmaceutical company reported its fiscal 2027 first-quarter results and announced a proposed acquisition by Rosemont Pharmaceuticals.
Aytu reported first-quarter revenue of $14.84 million, up 6.9% year over year from $13.89 million. Revenue topped the analyst estimate of $13.52 million by approximately 9.8%.
Aytu Biopharma shares jumped 42.9% to $2.60 in pre-market trading
Here are some other stocks moving in pre-market trading.
Gainers
- Cloudastructure Inc (NASDAQ:CSAI) rose 72.7% to $2.25 in pre-market trading following the company’s third-quarter results and business update.
- Basel Medical Group Ltd (NASDAQ:BMGL) jumped 38% to $0.42 in pre-market trading after dipping over 35% on Monday.
- Glass House Brands Inc. (NYSE:GLAS) gained 30.2% to $1.68 in pre-market trading after the company reported better-than-expected quarterly sales results.
- Safe Pro Group Inc. (NASDAQ:SPAI) gained 24% to $3.0503 in pre-market trading after posting strong quarterly results.
- Local Bounti Corporation (NYSE:LOCL) gained 16.5% to $0.74 in pre-market trading. Local Bounti entered into an agreement to purchase Revol Greens’ Two certified-organic controlled environment agriculture facilities located in Texas and Minnesota.
- Forum Markets, Incorporated (NASDAQ:FRMM) jumped 16.2% to $2.66 in pre-market trading. Forum Markets, last week, reported mixed third-quarter financial results.
- AEON Biopharma, Inc. (NYSE:AEON) rose 15.6% to $0.1637 in pre-market trading after posting a profit for the third quarter.
- Autozi Internet Technology (Global) Ltd. (NASDAQ:AZI) gained 11.4% to $0.5826 in pre-market trading after dipping 15% on Monday.
- Nixxy, Inc. (NASDAQ:NIXX) gained 17.2% to $0.1901 in pre-market trading. Nixxy, on Monday, posted a loss of 7 cents per share for the third quarter.
Losers
- Bridger Aerospace Group Holdings, Inc. (NASDAQ:BAER) fell 35.6% to $0.1548 in pre-market trading after the company reported worse-than-expected third-quarter financial results and cut its FY26 sales guidance below estimates.
- Stem, Inc. (NASDAQ:STEM) fell 32% to $1.34 in pre-market trading after the company reported worse-than-expected third-quarter financial results and cut its FY26 sales guidance below estimates. The company sold its Athena intellectual property to Voltus.
- Vivakor, Inc. (NASDAQ:VIVK) fell 29.4% to $0.2672 in pre-market trading after jumping 80% on Monday.
- Global Mofy AI Limited (NASDAQ:GMM) fell 25.8% to $1.49 in pre-market trading. Global Mofy shares jumped 97% on Monday after the company announced that it indirectly invested in Anthropic in September 2026.
- Red Cat Holdings, Inc. (NASDAQ:RCAT) fell 25.8% to $2.62 in pre-market trading after the company reported worse-than-expected third-quarter financial results and withdrew its FY26 revenue target.
- Cyabra, Inc. (NASDAQ:CYAB) tumbled 18.1% to $0.1121 in pre-market trading. Cyabra shares surged 54% on Monday after the company announced a $40 million investment over 3 years.
- Founder Group Limited (NASDAQ:FGL) fell 14.1% to $0.8764 in pre-market trading after gaining 6% on Monday.
- Indaptus Therapeutics, Inc. (NASDAQ:INDP) shares declined 10.1% to $3.10 in pre-market trading. Indaptus Therapeutics posted a third-quarter loss of a cent per share on Friday.
- Solid Biosciences Inc. (NASDAQ:SLDB) declined 7.4% to $6.00 in pre-market trading after dropping 5% on Monday.
- Braskem S.A. (NYSE:BAK) declined 5.4% to $0.92 in pre-market trading after dipping 14% on Monday.
Photo via Shutterstock
